Reactive site-modified tissue inhibitor of metalloproteinases-2 inhibits the cell-mediated activation of progelatinase A

被引:46
作者
Higashi, S [1 ]
Miyazaki, K [1 ]
机构
[1] Yokohama City Univ, Kihara Inst Biol Res, Div Cell Biol, Totsuka Ku, Yokohama, Kanagawa 244, Japan
关键词
D O I
10.1074/jbc.274.15.10497
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tissue inhibitor of metalloproteinases-a (TIMP-2) is supposed to play a regulatory role in the cell-mediated activation of progelatinase A To investigate the mechanism of the regulation, we prepared and characterized a chemically modified TIMP-2, and examined its effects on the activation of progelatinase A. We found that treatment of TIMP-2 with cyanate ion led to loss of inhibitory activity toward matrilysin or gelatinase A Structural and functional analyses of the modified TIMP-2 showed that carbamylation of the alpha-amino group of the NH2-terminal Cys(1) of TIMP-2 led to complete loss of the inhibitory activity. When the reactive-site modified TIMP-2 was added to culture medium of concanavalin A-stimulated HT1080 cells, the conversion of endogenous progelatinase A to the intermediate form was partially inhibited, whereas that of the intermediate form to the mature one was strongly inhibited. The reactive site-modified TIMP-2 also prevented an accumulation of active gelatinase A on the cell surface. We speculate that occupation of the hemopexin-like domain of gelatinase A by the reactive site-modified TIMP-2 makes it unable for gelatinase A to be retained on the cell surface, thus preventing the autocatalytic conversion of the intermediate fern of gelatinase A to its mature form.
引用
收藏
页码:10497 / 10504
页数:8
相关论文
共 28 条
[1]   Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes [J].
Atkinson, SJ ;
Crabbe, T ;
Cowell, S ;
Ward, RV ;
Butler, MJ ;
Sato, H ;
Seiki, M ;
Reynolds, JJ ;
Murphy, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (51) :30479-30485
[2]  
AZZAM HS, 1992, CANCER RES, V52, P4540
[3]   Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity [J].
Brooks, PC ;
Silletti, S ;
von Schalscha, TL ;
Friedlander, M ;
Cheresh, DA .
CELL, 1998, 92 (03) :391-400
[4]   Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3 [J].
Brooks, PC ;
Stromblad, S ;
Sanders, LC ;
vonSchalscha, TL ;
Aimes, RT ;
StetlerStevenson, WG ;
Quigley, JP ;
Cheresh, DA .
CELL, 1996, 85 (05) :683-693
[5]  
BROWN PD, 1990, CANCER RES, V50, P6184
[6]  
COLLIER IE, 1988, J BIOL CHEM, V263, P6579
[7]   THE MATRIX METALLOPROTEINASES AND THEIR NATURAL INHIBITORS - PROSPECTS FOR TREATING DEGENERATIVE TISSUE-DISEASES [J].
DOCHERTY, AJP ;
OCONNELL, J ;
CRABBE, T ;
ANGAL, S ;
MURPHY, G .
TRENDS IN BIOTECHNOLOGY, 1992, 10 (06) :200-207
[8]   Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor [J].
Fernandez-Catalan, C ;
Bode, W ;
Huber, R ;
Turk, D ;
Calvete, JJ ;
Lichte, A ;
Tschesche, H ;
Maskos, K .
EMBO JOURNAL, 1998, 17 (17) :5238-5248
[9]   Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1 [J].
GomisRuth, FX ;
Maskos, K ;
Betz, M ;
Bergner, A ;
Huber, R ;
Suzuki, K ;
Yoshida, N ;
Nagase, H ;
Brew, K ;
Bourenkov, GP ;
Bartunik, H ;
Bode, W .
NATURE, 1997, 389 (6646) :77-81
[10]  
Kinoshita T, 1996, CANCER RES, V56, P2535